1-8 of 8
Luca Bologna
Close
Sort by
Journal Articles

Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus

Sara Calzavarini, Raja Prince-Eladnani, François Saller, Luca Bologna, Laurent Burnier, Anne C. Brisset, Claudia Quarroz, Maria Desiré Reina Caro, Vladimir Ermolayev, Yasuhiro Matsumura, José A. Fernández, Tilman M. Hackeng, John H. Griffin, Anne Angelillo-Scherrer
Journal: Blood
Blood (2020) 135 (22): 1969–1982.
https://doi.org/10.1182/blood.2019003630
Published: 2020
Includes: Multimedia, Supplemental data
Journal Articles

Targeting anticoagulant protein S to improve hemostasis in hemophilia

Raja Prince, Luca Bologna, Mirko Manetti, Daniela Melchiorre, Irene Rosa, Natacha Dewarrat, Silvia Suardi, Poorya Amini, José A. Fernández, Laurent Burnier, Claudia Quarroz, Maria Desiré Reina Caro, Yasuhiro Matsumura, Johanna A. Kremer Hovinga, John H. Griffin, Hans-Uwe Simon, Lidia Ibba-Manneschi, François Saller, Sara Calzavarini, Anne Angelillo-Scherrer
Journal: Blood
Blood (2018) 131 (12): 1360–1371.
https://doi.org/10.1182/blood-2017-09-800326
Published: 2018
Includes: Supplemental data
Journal Articles

Blocking Protein S Improves Hemostasis in Hemophilia a and B

Luca Bologna, PhDstudent, Raja Prince, PhDstudent, Mirko Manetti, PhD, Daniela Melchiorre, MD, Irene Rosa, PhDstudent, Natacha Dewarrat, Poorya Amini, PhDstudent, Jose A Fernandez, Claudia Quarroz, Yasuhiro Matsumura, MD PhD, Johanna A Kremer Hovinga, MD PhD, Shida Yousefi, PhD, John H. Griffin, PhD, Simon Hans-Uwe, MD PhD, Lidia Ibba Manneschi, Francois Saller, PhD, Sara Calzavarini, PhD, Anne Angelillo-Scherrer, MD
Journal: Blood
Blood (2016) 128 (22): 79.
https://doi.org/10.1182/blood.V128.22.79.79
Published: 2016
Journal Articles

Glycoengineered CD20 Antibody Obinutuzumab Activates Neutrophils and Mediates Phagocytosis Through CD16B More Efficiently Than Rituximab

Josée Golay, PhD, Fabio Da Roit, BSc, Luca Bologna, BSc, Claudia Ferrara Koller, PhD, Jeanette H. W. Leusen, PhD, Alessandro Rambaldi, MD, Christian Klein, PhD, Martino Introna, MD
Journal: Blood
Blood (2013) 122 (21): 4419.
https://doi.org/10.1182/blood.V122.21.4419.4419
Published: 2013
Journal Articles

Blocking Protein S To Treat Hemophilia A

Luca Bologna, Sara Calzavarini, PhD, François Saller, PhD, Anne Angelillo-Scherrer
Journal: Blood
Blood (2013) 122 (21): 25.
https://doi.org/10.1182/blood.V122.21.25.25
Published: 2013
Journal Articles

Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab

Josée Golay, Fabio Da Roit, Luca Bologna, Claudia Ferrara, Jeanette H. Leusen, Alessandro Rambaldi, Christian Klein, Martino Introna
Journal: Blood
Blood (2013) 122 (20): 3482–3491.
https://doi.org/10.1182/blood-2013-05-504043
Published: 2013
Includes: Supplemental data
Journal Articles

Possible misinterpretation of the mode of action of therapeutic antibodies in vitro: homotypic adhesion and flow cytometry result in artefactual direct cell death

Josée Golay, Luca Bologna, Pierre-Alain André, Franz Buchegger, Jean Pierre Mach, Laurence Boumsell, Martino Introna
Journal: Blood
Blood (2010) 116 (17): 3372–3373.
https://doi.org/10.1182/blood-2010-06-289736
Published: 2010
Journal Articles

Predominant Complement Mediated Lysis of B-CLL Cells by Therapeutic MAbs Rituximab and Campath-1H in Whole Blood Assays.

Josee Golay, Luca Bologna, Elisa Gotti, Alessandro Rambaldi, Renato Bassan, Martino Introna, MD
Journal: Blood
Blood (2009) 114 (22): 3445.
https://doi.org/10.1182/blood.V114.22.3445.3445
Published: 2009